Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals

  Biotechnology Law Report
  Volume 26, Number 6, December 2007
  homepage                   other issues

  • Review Essay
  • Technogenesis Redesigns Phylogenesis: Or, When Liberation Biology Meets Our Posthuman Future
        Dinesh Sharma
        p.575-582                                                                              +cite        

  • Analysis of European Patent Law
  • Traditional Knowledge and Patenting: The Experience of the Neemfungicide and the Hoodia Cases
        Fritz Dolder
        p.583-590                                                                              +cite        

  • Regulatory Affairs—Pharmaceutical
  • Revisions of FDA Advisory Committee Procedures; Guidance on Preclinical Testing of Plasmid Vaccines; Reproductive Risk of CellCept; FDA Approves Test for Genetic Alterations in Warfarin Metabolism; How to Handle Spore Formers
        p.591-594                                                                              +cite    

  • Clinical Trials
  • FDA Criticized for Inadequate Overview of Clinical Trials
        p.595-596                                                                              +cite    

  • Regulatory Affairs—Agricultural and Environmental
  • EU Approves Some Genetically Engineered Crops; Testing for StarLink Corn May No Longer Be Mandatory
        p.597-598                                                                              +cite    

  • Patents
  • Pharmexa European Telomerase Patent Falls; PTO Tries to Bring Practice in Line with KSR; PTO Wants to Restrict Continuation Applications and Claim Numbers; SmithKline, Glaxo Sue; Two Affymetrix Patents Come Under PTO Scrutiny
        p.599-602                                                                              +cite    

  • Patent Litigation
  • Another Erythropoietin Win for Amgen; ImClone Settles Two Infringement Suits; Enzo Appeals Decision Favoring ABI in Litigation over Labeled Nucleotides; Markman Ruling Favors Oxford BioMedica, Sigma; Monsanto, Iowa State Settle on Low-Linolenic Acid Soybeans; Somerset Fails to Obtain Patent Term Extension; California Can Assert Sovereign Immunity; Syngenta Is Not Infringing Monsanto Patents, Some of Which Are Not Enabled; Judge Refuses to Revise Markman Constructions in Digene-Third Wave Litigation
        p.603-610                                                                              +cite    

  • Financial and Shareholder Affairs
  • Genzyme Settles Shareholder Suit; Immunocor Responds to FTC
        p.611-612                                                                              +cite    

  • Licensing and Collaborations
  • Immunocept Cannot Sue for Attorney Malpractice
        p.613-614                                                                              +cite    

  • Professional Practice
  • Immunocept Cannot Sue for Attorney Malpractice
        p.615-616                                                                              +cite    
  • Bibliography
        p.617-618                                                                              +cite    
  • On the Move
        p.619-620                                                                              +cite    

  • Texts
  • Office of Inspector General: The Food and Drug Administration's Oversight of Clinical Trials
        p.621-636                                                                              +cite    
  • Draft Guidance on Public Availability of Advisory Committee Members' Financial Interest Information and Waivers
        p.637-640                                                                              +cite    
  • Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications
        p.641-648                                                                              +cite    
  • Examination Guidelines for Determining Obviousness Under 35 U.S.C. 103 in View of the Supreme Court Decision in KSR International Co. v. Teleflex Inc.
        p.649-664                                                                              +cite    
  • Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably Indistinct Claims, and Examination of Claims in Patent Applications; Final Rule (excerpts)
        p.665-674                                                                              +cite    
  • Somerset Pharmaceuticals, Inc. v. Jon W. Dudas (2007-1447)
        p.675-676                                                                              +cite    
  • Biomedical Patent Management Corporation v. State of California, Department of Health Services (2006-1515)
        p.677-686                                                                              +cite    
  • Monsanto Company, Monsanto Technology LLC, and Dekalb Genetics Corp. v. Syngenta Seeds, Inc. et al. (2006-1472)
        p.687-694                                                                              +cite    
  • Digene Corporation v. Third Wave Technologies, Inc.
        p.695-700                                                                              +cite    
  • Immunocept, LLC, Patrice Anne Lee, and James Reese Matson v. Fulbright & Jaworski, LLP (2006-1432)
        p.701-706                                                                              +cite    
  • Coming Events
        p.707-711                                                                              +cite